Sarah Cannon Research Institute
Emily Correia is a skilled professional in business development and account management, currently serving as a DI Business Development Specialist and Portfolio Lead at Sarah Cannon Research Institute since August 2022. With experience at The HCI Group from June 2020 to July 2022 as a Client Partner and Account Executive, Emily contributed to advancing healthcare IT consulting and technology. Earlier in the career journey, Emily completed an internship with UCF Athletics Association Inc., where responsibilities included managing in-game duties and creating marketing materials to enhance brand awareness. Emily holds a Bachelor of Science in Business Administration with a focus on Integrated Business from the University of Central Florida, graduated in 2020.
This person is not in any teams
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.